Overweight Recommendation Issued On RAPP By Wells Fargo
Source: KlickAnalytics
2026-02-02 06:15:12 ET
Historical Analyst Recommendations
Latest 10 recommendations| Report Date Full story available on KlickAnalytics.com |
Rapport Therapeutics Inc.
NASDAQ: RAPP
RAPP Trading
10.98% G/L:
$31.935 Last:
57,452 Volume:
$30.35 Open:
RAPP Latest News
March 09, 2026 07:00:00 am
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
January 07, 2026 07:00:00 am
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
December 18, 2025 07:00:00 am
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
RAPP Stock Data
$1,346,118,602
30,701,034
0.05%
34
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
